London biotech firm to fund growth with cap hike
UK biotech firm Retroscreen Virology on Wednesday raised £33.6m through a sale of shares to new and existing investors that will allow the firm to fund its upcoming projects.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: